PUBLIC COMPANY
save$BHVNBiohaven Ltd.
$BHVN14.48+4.17%New Haven, CT, USupdated 14d ago
community read0 votes
pipeline
5
marketed
0
phase 3
3
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 23Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Significant stock movers of October: Biohaven climbs, ArriVent divesA fresh FDA review for Biohaven’s embattled ataxia drug lifted the biotech's shares, while a late-stage lung cancer miss battered ArriVent, which failed to rebound even after encouraging early ADC…biospace · 18d ago
- Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drugThe enrollment pause comes after BHV-7000 failed to show efficacy in a midstage depression trial late last year. The news is another regulatory hit for Biohaven after the FDA declined to approve it…biospace · 2mo ago
Data sources
last refreshed 34m ago
Found something off?
comments(0)
5-min edit window · permanent after that